Dr. Jonathan Charles Seccombe, MD

Dr. Seccombe practices at Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health.

Dr. Seccombe's NPI, 1124255849, was assigned on June 20, 2009. Dr. Seccombe graduated from Emory University School of Medicine in 2009. Dr. Seccombe holds Missouri license 2011037708.

Dr. Seccombe's primary practice is Missouri Baptist Medical Center, at 3015 N Ballas Rd, Saint Louis, MO 63131 in St. Louis County. The practice phone is (314) 996-5000.

Dr. Seccombe's primary practice is Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health. Dr. Seccombe is also affiliated with Barnes-Jewish Hospital. The medical group on file is BJC Medical Group. Dmand AI also links Dr. Seccombe to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seccombe practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Seccombe's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Seccombe is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Seccombe is licensed in Missouri.

CMS data shows 417 Medicare services from Dr. Seccombe across 10 procedure codes in 2024, for 306 Medicare patients. Medicare paid $40,306 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 306 Medicare patients who saw Dr. Seccombe in 2024. The largest group is 75 to 84, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seccombe's median patient age at 70, with 57% women.

In 2024, Dr. Seccombe wrote 137 Medicare Part D claims for 84 patients. 88% of them were for generic drugs. CMS names the drug for 73 of them, across 3 drugs with 11 or more claims each, at $910 in total drug cost. In 2023, CMS named 867 claims across 24 drugs.

Dr. Seccombe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 210 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Seccombe, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Seccombe, published from 2012 to 2013. Dr. Seccombe's most frequent co-authors are Chandra Prakash Gyawali, MD, Gregory A. Ewald, MD and Vladimir Markovicl Kushnir, MD.

Dmand AI links Dr. Seccombe to 1 clinical trial. Conditions studied include Hemorrhage and Anemia.

CMS Open Payments shows 53 general payments to Dr. Seccombe from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Prometheus Laboratories Inc. paid the most, $305.

Dr. Seccombe graduated from Emory University School of Medicine in 2009.